Skip to content

CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please consider our Risk Disclosure Notice and ensure that you fully understand the risks involved. CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please consider our Risk Disclosure Notice and ensure that you fully understand the risks involved.

ASX 200 surges 219 points as new coronavirus cases slow

We examine some of the key market moves and analyst updates from Monday, 6 April.

ASX 200 Source: Bloomberg

With news emerging that the spread of the novel coronavirus in Australia has begun to slow, financial markets reacted in an unsurprisingly bullish manner today.

Specifically, the ASX 200 finished out the day at the 5286 point level – up some 219 points or 4.33%.

At the time of writing, Australia’s coronavirus case count stood at 5,788; while total deaths stemming from the virus have reached 39. Positively, some 2,315 individuals have reportedly recovered from the virus.

ASX 200 market news and developments

As bullishness again returns, all sectors managed to finish out the day higher. This change in mood comes after the ASX 200 dropped 1.68% on Friday.

Energy stocks were the best performing here, with the ASX 200 Energy Index (XEJ) finishing out the day up 5.70%; followed by the A-REIT Index (XXJ), which gained 4.79%; and the Financial Index (XFJ), which added 4.72% and finished out the day at 4,302 points.

By comparison, the Industrials sector was the worst performing of the day, with the XNJ index closing out Monday up ‘just’ 2.25% – at the 4,951 point level.

On a more granular level, Corporate Travel Management, Pilbara Minerals and HUB24 were Australia's best performing equities; while Webjet, NextDC and IDP Education were the worst performing.

Looking at some of Monday's other key developments: Flight Centre announced that it was gearing up for a $700 million equity raise; Oil Search was placed in a trading halt pending news concerning its own capital raise; antimicrobial micro-cap Zoono revealed a strong up-tick in Q3 sales; Seek announced it would be deferring its Interim Dividend; Origin Energy provided an operational and financial update to the market; and Paradigm Biopharma joined a growing list of companies set to tap the market for fresh capital.

Upgrades, downgrades and everything in between

Elsewhere, Macquarie Wealth Management lowered its price target on outdoor retailer Kathmandu to $0.98 per share (from $1.57 per share); Morgan Stanley argued that Afterpay may be set to benefit from Covid-19 induced 'online tailwinds', though the investment bank retained its Equal-weight rating and $19.00 per share price target; JP Morgan prophetically flagged Oil Search’s 'debt metrics' as stretched; Bell Potter upgraded its recommendation on Suncorp from Hold to Accumulate; and Citibank lowered its price target on Ramsay Health Care from $75.00 per share to $70.00 per share – though retained its Buy recommendation.

How to trade markets – long or short

What do you make of today’s bullish price action: Is it sustainable or not? Whatever your opinion, you can trade indices, currencies and equities – both up and down – through IG’s trading platform now.

For example, to buy (long) or sell (short) the ASX 200 using CFDs, follow these easy steps:

  • Create an IG Trading Account or log in to your existing account
  • Enter ‘Australia 200’ or ‘ASX 200’ in the search bar and select it
  • Choose your position size
  • Click on ‘buy’ or ‘sell’ in the deal ticket
  • Confirm the trade

The information on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG Bank S.A. accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer.

Act on share opportunities today

Go long or short on thousands of international stocks with CFDs.

  • Get full exposure for a comparatively small deposit
  • Trade on spreads from just 0.1%
  • Get greater order book visibility with direct market access

See opportunity on a stock?

Try a risk-free trade in your demo account, and see whether you’re on to something.

  • Log in to your demo
  • Take your position
  • See whether your hunch pays off

See opportunity on a stock?

Don’t miss your chance – upgrade to a live account to take advantage.

  • Trade a huge range of popular stocks
  • Analyse and deal seamlessly on fast, intuitive charts
  • See and react to breaking news in-platform

See opportunity on a stock?

Don’t miss your chance. Log in to take your position.

Live prices on most popular markets

  • Forex
  • Shares
  • Indices

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.